
Preparing for Regulatory Inspections
Regulatory compliance is of paramount importance to pharmaceutical and biopharmaceutical companies, which must be continually prepared for inspections by FDA, EMA, and other health authorities to meet requirements for good clinical practices (GCP) and good manufacturing practices (GMP).
Regulatory compliance is of paramount importance to pharmaceutical and biopharmaceutical companies, which must be continually prepared for inspections by FDA, EMA, and other health authorities to meet requirements for good clinical practices (GCP) and good manufacturing practices (GMP). Pharmaceutical Technology will present an educational webcast on Thursday Nov. 7th from 1:00 to 2:00 PM EST,
Successful GCP/GMP inspections can be achieved only through well-controlled laboratory, manufacturing, and quality systems with efficient access to related documentation and information. Often, technical limitations in content-management systems result in unsuccessful inspections. This 60-minute
The panelists for the
Documentum for Life Sciences, EMC Corporation; and Adam Kelch, Product Manager, Documentum for Life Sciences, EMC Corporation. Viewers can ask questions of the panelists to gain further insight into how to meet regulators’ expectations and requirements for successful GCP/GMP inspections and how to optimize laboratory, manufacturing, and quality systems to provide efficient access for related documentation and information to ensure successful inspections.
Additional information and to register for the Pharmaceutical Technology webcast, “Ensuring Preparedness for Regulatory Inspections,” for Thursday Nov. 7th from 1:00 to 2:00 PM EST may be found
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.


